Pharma-Bio Serv (PBSV) Change in Receivables (2010 - 2026)
Pharma-Bio Serv (PBSV) reported Change in Receivables of $77977.0 for Q2 2026, up 224.82% year-over-year from $24006.1 in Q2 2025, and down 71.86% on a QoQ basis from $277116.0 in Q1 2026.
Pharma-Bio Serv (PBSV) Change in Receivables (2010 - 2026) Analysis & Trends
Pharma-Bio Serv's Change in Receivables history runs 17 years deep, the most recent figure standing at $77977.0 for Q2 2026.
- Change in Receivables for Q2 2026 came in at $77977.0, up 224.82% year-over-year; the trailing twelve-month figure through Apr 2026 was $27556.0 (up 46.81% YoY), and the FY2025 annual result was -$203643.0, up 86.02% from the prior year.
- Change in Receivables came in at $77977.0 for Q2 2026 at Pharma-Bio Serv, down from $277116.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $663696.0 in Q2 2023 to a low of -$1.6 million in Q1 2024.
- A 5-year average of -$65973.1 and a median of $132171.0 in 2025 frame the typical range for Change in Receivables.
- The largest YoY upside for Change in Receivables was 489.17% in 2025 against a maximum downside of 4189.74% in 2025.
- Over 5 years, Change in Receivables stood at -$205939.0 in 2022, then tumbled by 650.94% to -$1.5 million in 2023, then soared by 94.22% to -$89380.0 in 2024, then surged by 489.17% to $347839.0 in 2025, then plunged by 77.58% to $77977.0 in 2026.
- The last three Change in Receivables figures came in at $77977.0 (Q2 2026), $277116.0 (Q1 2026), and $347839.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | -696.61 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 114.13 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | -1.69 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 48.86 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | -18.13 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | -11.72 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | -3.24 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 112.77 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 33.30 Mn |
| 10 | Pharma-Bio Serv | - | - | 902,041.00 | 77,977.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 77,977.00 |
| Apr 30, 2026 | 77,977.00 |
| Jan 31, 2026 | 277,116.00 |
| Jan 31, 2026 | 277,116.00 |
| Oct 31, 2025 | 347,839.00 |
| Oct 31, 2025 | 347,839.00 |
| Jul 31, 2025 | -675,376.00 |
| Jul 31, 2025 | -675,376.00 |
| Apr 30, 2025 | -62,471.00 |
| Apr 30, 2025 | -62,471.00 |
| Jan 31, 2025 | 186,365.00 |
| Jan 31, 2025 | 186,365.00 |
| Oct 31, 2024 | -89,380.00 |
| Oct 31, 2024 | -89,380.00 |
| Jul 31, 2024 | -15,744.00 |
| Jul 31, 2024 | -15,744.00 |
| Apr 30, 2024 | 209,313.00 |
| Apr 30, 2024 | 209,313.00 |
| Jan 31, 2024 | -1.56 Mn |
| Jan 31, 2024 | -1.56 Mn |